Patients can benefit from clinical trials in gynecologic cancers, and knowing that they can advocate for themselves for potential consideration for study enrollment.
Spencer Feldman
Advertisement
Spencer, Assistant Editor of CURE®, has been with MJH Life Sciences since 2024. A graduate of Rowan University with a bachelor's degree in health communication, Spencer manages CURE's Facebook, Instagram and YouTube. He also enjoys spending time with family and friends, hiking, playing guitar and rock climbing.
Articles by Spencer Feldman
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
KTX-1001 Elicits Responses in Some With Multiple Myeloma
3
New Combination Treatment Approach Studied in Pancreatic Cancer
4
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
5